ArticleBlood advances2022

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma.

Anusara Daenthanasanmak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.